Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths News Regulatory News (SNWS)

Share Price Information for Smiths News (SNWS)

Share Price is delayed by 15 minutes
Get Live Data
67.20    -0.60 (-0.88%)
Bid:
66.60
Ask:
67.60
Spread: 1.00 (1.502%)
Market Cap: £162.65m
SNWS Live PriceLast checked at - London Stock Exchange

Intraday Smiths News Share Chart

Contract Renewal - Associated Newspapers

19 Oct 2022 07:00

RNS Number : 3036D
Smiths News PLC
19 October 2022
 

This announcement contains inside information

 

Smiths News PLC

("Smiths News")

 

Contract Renewal with Associated Newspapers Limited

 

Smiths News is pleased to announce that it has successfully secured a new long-term contract with Associated Newspapers Limited, publisher of the 'Daily Mail', 'The Mail on Sunday' and the 'i' newspaper.

The new agreement reached with Associated Newspapers represents the first of the major newspaper publisher contract renewals and follows closely on from this week's announcement of Smiths News having successfully secured new 5 year magazine distribution agreements with each of Frontline and Seymour.

The new agreement with Associated Newspapers is for all of Smiths News' current distribution territories in the UK through to 2029, representing revenues of c.£155m p.a. at current market values.

Combined with Frontline and Seymour, this now means that Smiths News has secured long-term contracts with 35% of its newspaper and magazine revenues. The new contracts are an endorsement of the future of the printed newspaper and magazine categories and confirm Smiths News' leading position in the sector.

Jon Bunting, Chief Executive Officer, commented:

"I am delighted that we have agreed a new contract with Associated Newspapers, building upon the recently announced Frontline and Seymour renewals. We look forward to working with Associated Newspapers to ensure the widespread access and availability of their titles for readers and continuing to demonstrate the pivotal role we play in the supply chain. Renewal of our publisher contracts remains a strategic priority for the business, underpinning the long-term sustainability of the business."

 

 

Enquiries:

Smiths News PLC

Jonathan Bunting, Chief Executive Officer

Paul Baker, Chief Financial Officer

www.smithsnews.co.uk

Via Buchanan

Buchanan

Richard Oldworth / Jamie Hooper / Toto Berger

smithsnews@buchanan.uk.com

www.buchanan.uk.com

020 7466 5000

Person responsible for arranging release of this announcement:

Stuart Marriner

General Counsel & Company Secretary

Smiths News plc

Rowan House

Cherry Orchard North

Kembrey Park

Swindon

SN2 8UH

email: cosec@smithsnews.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTXVLFFLBLEFBE
Date   Source Headline
17th Jun 20267:00 amRNSContract Win - National Distribution
6th May 20267:00 amRNSInterim Results as at 28 February 2026
19th Mar 20267:00 amRNSContract Renewal with The Guardian
27th Feb 20263:00 pmRNSBlock listing Interim Review
23rd Feb 20267:00 amRNSStatement re Tuffnells Parcels Express Pension
10th Feb 20265:32 pmRNSDirector/PDMR Shareholding - Correction
3rd Feb 20262:18 pmRNSDirector/PDMR Shareholding
29th Jan 20262:25 pmRNSResult of Annual General Meeting
29th Jan 20267:00 amRNSTrading Statement
6th Jan 202611:48 amRNSHolding(s) in Company
16th Dec 20254:55 pmRNSNotice of AGM
12th Dec 20255:15 pmRNSDirector/PDMR Shareholding
9th Dec 20252:11 pmRNSDirector/PDMR Shareholding
3rd Dec 202512:08 pmRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 202510:38 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSPreliminary Results
6th Oct 20257:00 amRNSNotice of Results and CFO Transition
23rd Sep 20257:00 amRNSTrading Statement
1st Sep 20254:20 pmRNSBlock listing Interim Review
31st Jul 20257:00 amRNSAppointment of Chief Financial Officer
7th May 20257:00 amRNSHalf-year Report
28th Mar 20257:00 amRNSTrading Statement
4th Mar 20257:00 amRNSDirectorate Change
28th Feb 202511:27 amRNSBlock listing Interim Review
16th Jan 20251:50 pmRNSResult of AGM
16th Jan 20257:00 amRNSTrading Statement
7th Jan 20257:00 amRNSBoard Changes
13th Dec 20241:13 pmRNSNotice of AGM
12th Dec 20243:09 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSContract Renewal Reach PLC
29th Nov 20242:47 pmRNSDirector/PDMR Shareholding
29th Nov 20242:45 pmRNSDirector/PDMR Shareholding
29th Nov 20242:44 pmRNSDirector/PDMR Shareholding
29th Nov 20242:43 pmRNSDirector/PDMR Shareholding
29th Nov 20249:16 amRNSDirector/PDMR Shareholding
14th Nov 20243:23 pmRNSDirector/PDMR Shareholding
8th Nov 202411:47 amRNSHolding(s) in Company
6th Nov 20242:44 pmRNSHolding(s) in Company
6th Nov 202411:44 amRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSFinal Results
18th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
17th Oct 20249:37 amRNSNotice of Full Year Results
14th Oct 20249:28 amRNSHolding(s) in Company
2nd Oct 20247:00 amRNSPost Close Trading Statement
2nd Sep 20249:46 amRNSBlock listing Interim Review
2nd May 20247:00 amRNSHalf-year Report
2nd May 20247:00 amRNSRefinancing Agreement
18th Apr 20247:00 amRNSNotice of Results
1st Mar 20248:18 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.